Price$0.37+0.10 (+36.13%)
2026-03-092026-06-10
News · 26 weeks25-40%
2025-12-142026-06-07
Mix2090d
- SEC Filings11(55%)
- Other5(25%)
- Earnings4(20%)
Latest news
25 items- SECSEC Form PRER14A filed by Milestone Scientific Inc.PRER14A - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECSEC Form EFFECT filed by Milestone Scientific Inc.EFFECT - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECSEC Form 424B1 filed by Milestone Scientific Inc.424B1 - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECSEC Form PRE 14A filed by Milestone Scientific Inc.PRE 14A - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECSEC Form S-3 filed by Milestone Scientific Inc.S-3 - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- PRMilestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain ProceduresROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued growth in clinical adoption and physician acceptance of its CompuFlo® Epidural System following the publication of new peer-reviewed research from the University of Texas Medical Branch (UTMB). The newly published study in Operative Neurosurgery demonstrated that CompuFlo-guided epidural access during spinal cord stimulator (SCS) implantation procedures was associated with significantly lower complication rates compared with conventional loss-of-resistance
- PRMilestone Scientific Reports Financial Results for First Quarter 2026Operating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026. "Our first quarter results reflect continued progress as we execute on the foundation established in 2025," said Eric Hines, Chief Executive Officer of Milestone Scientific. "We delivered meaningful improvements in opera
- SECSEC Form 10-Q filed by Milestone Scientific Inc.10-Q - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- PRMilestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference CallROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 14, 2026, to discuss the company's financial results for the first quarter ended March 31, 2026, as well as the company's corporate progress and other developments. The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 950491. A live webcast and replay are available here: htt
- PRMilestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical AdoptionROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinical engagement, and continued development of its commercial and reimbursement infrastructure. Advisor Program Driving Utilization and Real-World Data Generation Since launching the CompuFlo® Advisor Program in February 2026, the Company has onboarded physician advisors and initiated procedural use across key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast Service O
- SECMilestone Scientific Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECMilestone Scientific Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECAmendment: SEC Form 10-K/A filed by Milestone Scientific Inc.10-K/A - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECSEC Form D filed by Milestone Scientific Inc.D - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECMilestone Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- PRMilestone Scientific Inc. Completes $2.15 Million Private PlacementROSELAND, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of a $2.15 million private placement of common stock and warrants, and an additional $2.69 million if cash warrants are fully exercised. "Today we strengthened our balance sheet and positioned the company to capitalize on the increasing demand we are seeing across our product platforms," said Eric Hines, Chief Executive Officer of Milestone Scientific. "This financing allows us to build on our progress, scaling investment in sales, inventory and digital marketing, wh
- SECMilestone Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- PRMilestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ended December 31, 2025. Eric Hines, Chief Executive Officer of Milestone Scientific commented: "When I joined Milestone in August 2025, we were in the middle of the third quarter following a period without consistent execut
- SECSEC Form 10-K filed by Milestone Scientific Inc.10-K - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- PRMilestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference CallROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 1, 2026, to discuss the company's financial results for the fourth quarter and full year ended December 31, 2025, as well as the company's corporate progress and other developments. The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 875878. A webcast and replay of the
- PRMilestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National ExpansionROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates. The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian,
- SECAmendment: Milestone Scientific Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- SECMilestone Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
- PRMilestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in DentistryROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the launch of The Wand® Ambassador Program, a scalable peer-to-peer engagement initiative designed to expand clinical awareness, education, and adoption of The Wand® STA (Single Tooth Anesthesia®) System within the dental market. The program leverages experienced dental professionals to share real-world clinical insights, workflow considerations, and firsthand experiences with colleagues. This peer-driven approach is intended to increase high-quality engagement with prospective p
- SECMilestone Scientific Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - MILESTONE SCIENTIFIC INC. (0000855683) (Filer)
MLSS FAQ
6 questionsWhat does Milestone Scientific Inc. do?
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs...Where does MLSS stock trade?
Milestone Scientific Inc. (MLSS) is listed on AMEX.What sector and industry is MLSS in?
Milestone Scientific Inc. operates in the Health Care sector, Industrial Specialties industry.When did Milestone Scientific Inc. go public?
Milestone Scientific Inc. (MLSS) completed its IPO in 2015.What companies are similar to MLSS?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare MLSS side-by-side with any of them on Quantisnow.How can I track MLSS on Quantisnow?
Quantisnow aggregates Milestone Scientific Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MLSS to receive live email and push alerts on every new disclosure.